Alto Neuroscience, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ANRO research report →
About the company
Alto Neuroscience, Inc. operates as a biopharmaceutical entity in the clinical stage, specializing in the creation of novel psychiatric medications. Its development pipeline includes ALTO-100, an investigational therapy targeting individuals affected by major depressive disorder (MDD) and post-traumatic stress disorder.
- CEO
- Amit Etkin
- IPO
- 2024
- Employees
- 76
- HQ
- Mountain View, CA, US
Price Chart
- Market Cap
- $869.63M
- P/E
- -10.97
- P/S
- 0.00
- P/B
- 3.35
- EV/EBITDA
- -8.58
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -47.22%
- ROIC
- 20.70%
- Revenue
- $0 · 0.00%
- Net Income
- $-63,238,000 · -2.94%
- EPS
- $-2.19 · 12.40%
- Op Income
- $-66,364,000
- FCF YoY
- -4.63%
- 52W High
- $28.44
- 52W Low
- $2.28
- 50D MA
- $22.88
- 200D MA
- $17.32
- Beta
- 1.25
- Avg Volume
- 408.22K
Get TickerSpark's AI analysis on ANRO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 27, 26 | Miller Andrew Craig | other | 26,000 |
| May 27, 26 | Miller Andrew Craig | other | 0 |
| May 14, 26 | Etkin Amit | other | 400,000 |
| May 12, 26 | Sanchez Ramiro | other | 10,958 |
| May 12, 26 | Cox Christopher Nixon | other | 10,958 |
| May 12, 26 | Manji Husseini | other | 10,958 |
| May 12, 26 | Dreyfus Andrew | other | 10,958 |
| May 12, 26 | York Gwill | other | 10,958 |
| Mar 1, 26 | Etkin Amit | other | 6,227 |
| Mar 1, 26 | Smith Nicholas Conrad | other | 2,806 |
Our ANRO coverage
Recent articles, reports, and earnings notes.
No research on ANRO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ANRO report →Similar companies
Peers in the same neighborhood.